| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.039 | 0.5 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.037 | 0.5 |